Sentence examples for expected to bleed from inspiring English sources

Staff members on both sides began poring through the 800-page spending bill, preparing for a vote as early as Friday, though the entire process is expected to bleed into the weekend.

iPad is expected to bleed market share to cheap Android rivals all through the 2013.

Severely thrombocytopenic patients would be expected to bleed more and therefore receive more RBC transfusions, but this was not the case.

In case of a contamination by the poststimulus period, a statistical maximum at this time range would be expected to bleed into the prestimulus time range, which is not indicated by the spectro-temporal pattern of the network effects.

"We were encouraged because we expected to be bleeding votes there," a Democratic official said.

A 200% increase in apixaban exposure would be expected to increase bleeding risk by 39%; however, such increased exposures were not seen during any clinical trials.

A 100% increase in apixaban exposure is expected to raise bleeding frequencies to 7.25% (TKR) and 10.9% (THR), whereas a 200% increase would raise them to 8.49 and 12.7%.

The effect of covariate combinations that increase apixaban exposure (female gender, age > 75 years, cCrCL < 30 ml/min, and body weight < 50 kg) would be expected to increase bleeding risk by 11% (Table 1 ).

Increases in apixaban exposure of 100% would be expected to increase bleeding risk by 18% relative to a reference population and represents the change in exposure that might be encountered in the presence of a strong inhibitor of cytochrome P3A4 and P-glycoprotein.

Therefore, limiting invasive procedures before and during infusion of drotrecogin alfa (activated), as well as minimizing risks associated with procedures (e.g. instrumentation of blood vessels in which direct compression might be expected to control bleeding), could improve the safety profile of the drug.

CSL112, when co-administered with standard DAPT, did not significantly influence platelet aggregation in response to agonists and is, therefore, not expected to significantly increase bleeding risk when administered with antiplatelet therapies.